Inventor · disambiguated record
Jya-Wei Cheng
Also filed as: CHENG JYA-WEI
10 granted patents·9 pending applications·16 citations·filing 2002–2024
81Inventor score
Files withUNIV NAT TSING HUA7CHENG JYA-WEI4RISE BIOPHARMACEUTICALS INC4LT BIOPHARMA INC1RISE TECH CO LTD1
Top patents by PatentIndex Score
19 records- 0184US9073967B2High salt-resistance antibacterial peptide and method for producing the sameCHENG JYA-WEI·Filed 2012·Granted Jul 7, 2015·8 cites·5 claims
- 0280US9090655B2Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereofCHENG JYA-WEI·Filed 2011·Granted Jul 28, 2015·6 cites·11 claims
- 0368US10611799B2Anti-endotoxin polypeptideUNIV NAT TSING HUA·Filed 2017·Granted Apr 7, 2020·2 cites·3 claims
- 0460US2025312277A1Pegylated liposomes and uses thereofLT BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0560US2023338463A1Icd peptide and use thereof for having cytotoxic activity on cancer cellsUNIV NAT TSING HUA·Filed 2023·Application pending·0 cites
- 0658US2024041975A1Anticancer peptide and use thereof for inhibiting cancer cell viabilityUNIV NAT TSING HUA·Filed 2023·Application pending·0 cites
- 0754US12472227B2Pharmaceutical compositions and use thereof for relieving resistance due to cancer chemotherapy and enhancing effect of cancer chemotherapyRISE BIOPHARMACEUTICALS INC·Filed 2021·Granted Nov 18, 2025·0 cites·3 claims
- 0854US9873719B2Salt and protease-resistance of antimicrobial peptide and the manufacture thereofUNIV NAT TSING HUA·Filed 2014·Granted Jan 23, 2018·0 cites·4 claims
- 0954US2023340019A1Icd peptide and use thereof for having cytotoxic activity on cancer cellsUNIV NAT TSING HUA·Filed 2022·Application pending·0 cites
- 1052US12329804B2Modified chemokine peptide and use thereofRISE BIOPHARMACEUTICALS INC·Filed 2020·Granted Jun 17, 2025·0 cites·4 claims
- 1151US2006128614A1Antimicrobial peptides with reduced hemolysis and methods of their useCHENG JYA-WEI·Filed 2004·Application pending·0 cites
- 1250US2025250298A1Oncolytic peptide and use thereofRISE BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1345US12226454B2Pharmaceutical compositions and use thereof for relieving anticancer drug resistance and enhancing sensitivity of anticancer drugRISE BIOPHARMACEUTICALS INC·Filed 2020·Granted Feb 18, 2025·0 cites·3 claims
- 1445US2004072990A1Antimicrobial peptides with reduced hemolysis and methods of their useFiled 2002·Application pending·0 cites
- 1539US8536116B2Antagonists for diseases induced by cells with high-affinity ELR-CXC chemokine receptor proteinsCHENG JYA-WEI·Filed 2012·Granted Sep 17, 2013·0 cites·11 claims
- 1638US10810329B2In silico design of peptides equilibrated in a lipid bilayer with partition free energies indicating probability of antimicrobial activityUNIV NAT TSING HUA·Filed 2016·Granted Oct 20, 2020·0 cites·7 claims
- 1734US10093699B2Peptides with antimicrobial, anticancer and/or wound-healing promoting activities, pharmaceutical compositions containing the same, and use of the peptides with antimicrobial, anticancer and/or wound-healing promoting activitiesUNIV NAT TSING HUA·Filed 2016·Granted Oct 9, 2018·0 cites·31 claims
- 1834US2018125938A1Modified chemokine peptideRISE TECH CO LTD·Filed 2015·Application pending·0 cites
- 1934US2004241217A1Method for administration of immune modulators in systemic and localized immune disordersFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →